Advent In Talks To Buy Sanofi Euro Generics Arm For $2.3B
Advent International is in exclusive talks that could see the private equity firm snap up Sanofi SA's European generics unit for €1.9 billion ($2.3 billion), the companies said Tuesday, the day...To view the full article, register now.
Already a subscriber? Click here to view full article